Acrobat Genomics logo — Accelerating safe and effective medicines to cure genetic di...

Acrobat Genomics

Accelerating safe and effective medicines to cure genetic diseases

Founded 2022 United States San Carlos, United States 4 employees Pre-Seed Biotechnology

General Information

Company Name Acrobat Genomics
Founded Year 2022
Location United States San Carlos, United States
Employees 4
Industries Biotechnology
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Acrobat Genomics. To contact Acrobat Genomics, visit acrobatgenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Acrobat Genomics

Acrobat Genomics is an early-stage, VC-backed biotech startup founded in 2022. The company's mission is to invent impactful technologies that will lead to curative therapeutics for genetic diseases. Coming from a leading CRISPR lab at Stanford University, Acrobat Genomics specializes in leveraging DNA technologies and machine learning for high-throughput biology. Located within the MBC BioLabs in San Carlos, CA, a well-equipped modern lab space, the company benefits from a rich community of companies building game-changing technologies. The startup's slogan "Accelerating safe and effective medicines to cure genetic diseases" reflects its overarching goal. Acrobat Genomics recently secured a Pre Seed Round investment on 01 January 2023 from Taihill Venture. This investment signifies confidence from a notable VC firm and reflects potential for future growth and success.

Taxonomy: biotech startup, genetic diseases, CRISPR, single cell genomics, gene editing, DNA technologies, therapeutics, MBC BioLabs, Stanford University, curative medicine, venture capital, high-throughput biology, innovation, cure

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
Taihill Venture
01 Jan 2023
Non Equity Assistance Undisclosed 1
Illumina Accelerator
14 Sep 2022

Acrobat Genomics Alternatives & Competitors

View All Alternatives
Acrobat Genomics vs
GenEditBio Limited
GenEditBio Limited Hong Kong S.a.r.

A biotech startup company aiming to provide potentially curative gene editing-based solutions for ge...

Seed
18 employees
Biotechnology
Acrobat Genomics vs
Ligandal
Ligandal United States

Ligandal is developing precision molecular therapeutics and targeted delivery technologies.

Seed
12 employees
Biotechnology
Acrobat Genomics vs

On-target gene therapies

Seed
15 employees
Biotechnology, Health and Wellness

FAQ About Acrobat Genomics

Accelerating safe and effective medicines to cure genetic diseases
Acrobat Genomics was founded in 2022.
Acrobat Genomics is headquartered in San Carlos, United States.
Acrobat Genomics operates in Biotechnology. Its work centres on biotech startup, genetic diseases, CRISPR and single cell genomics.
Acrobat Genomics has approximately 4 employees.
Acrobat Genomics has completed 2 funding rounds. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Acrobat Genomics include GenEditBio Limited, Ligandal, Alia Therapeutics, Integra Therapeutics, Graphite Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acrobat Genomics and GenEditBio Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Acrobat Genomics, https://bouncewatch.com/company/acrobat-genomics, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes